N-Methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine

Catalog No. :
ACFIJG625
CAS No. :
880361-90-0
Molecular Formula :
C10H11N3O
Molecular Weight :
189.22

IUPAC Name:N-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine

N-Methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$136.00Login to see priceInquiryInquiry
5g97%$486.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine
IUPAC NameN-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine
MDL No.MFCD07186444
Molecular FormulaC10H11N3O
Molecular Weight189.22
SMILESCNCC1=NN=C(C2=CC=CC=C2)O1
InChI KeyWVVQCQZLRFXKEZ-UHFFFAOYSA-N
SynonymMETHYL-(5-PHENYL-[1,3,4]OXADIAZOL-2-YLMETHYL)-AMINE;CHEMBRDG-BB 4100686;CBI-BB ZERO/004816;ASINEX-REAG BAS 10155091;N-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine(SALTDATA: HCl);N-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine 1HCl;1,3,4-Oxadiazole-2-methanamine, N-methyl-5-phenyl-;N-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine
CAS No.880361-90-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFIJG625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIOGS273 route compound structure diagram
    ACIOGS27333575-83-6 In Stock
  4. Then
  5. ACFIJG625 route product structure diagram
    ACFIJG625880361-90-0
Inquiry

2. ACFIJG625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFIJG625 route product structure diagram
    ACFIJG625880361-90-0
Inquiry

Comments (0)